Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Finally, Progress in Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction

Wassim H Fares1, Naftali Kaminski1

  • 11 Section of Pulmonary, Critical Care and Sleep Medicine Department of Medicine Yale University School of Medicine New Haven, Connecticut.

American Journal of Respiratory Cell and Molecular Biology
|April 1, 2017
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aberrant and Ectopic Cell Populations in Restrictive Allograft Syndrome after Lung Transplantation.

The European respiratory journal·2026
Same author

SPEAK: Spatial Prompting with Expert Aligned Knowledge for Tissue Domain Identification in Spatial Transcriptomics.

bioRxiv : the preprint server for biology·2026
Same author

Alveolar niche disruption and aberrant epithelial reprogramming are early hallmarks of idiopathic pulmonary fibrosis.

bioRxiv : the preprint server for biology·2026
Same author

A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.

The European respiratory journal·2026
Same author

Early Pulmonary Fibrosis is Defined by Niche- and Cell-Specific Molecular Programs.

bioRxiv : the preprint server for biology·2026
Same author

Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and <i>TLR5</i> deficiency is associated with human IPF.

Science translational medicine·2026